The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Oral Proteins and Peptides Market Outlook 2022

Global Oral Proteins and Peptides Market Outlook 2022

Publishing Date : Dec, 2021

License Type :
 

Report Code : 1635285

No of Pages : 119

Synopsis
Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and protein-based drugs.

The oral protein and peptide-based therapeutics market for diabetes is expected to grow considerably in the near future, owing to factors such as increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle.

The global Oral Proteins and Peptides market was valued at US$ 751.8 million in 2020 and is expected to reach US$ 1214.6 million by the end of 2027, growing at a CAGR of 6.6% during 2021-2027.

This report focuses on Oral Proteins and Peptides volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Oral Proteins and Peptides market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Oral Proteins and Peptides Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Linaclotide
  • Calcitonin
  • Insulin
  • Octreotide

Segment by Application

  • Gastric & Digestive Disorders
  • Bone Diseases
  • Diabetes
  • Hormonal Disorders

By Region

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
  • Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)

By Company

  • Allergan
  • AstraZeneca
  • Biocon
  • Generex Biotechnology
  • Novo Nordisk
  • Synergy Pharmaceuticals
  • Tarsa Therapeutics
  • Sanofi
  • Hoffmann-La Roche
  • Synthetic Biologics
  • Hovione
  • Novartis

Scope of the Oral Proteins and Peptides Market Report

Report Metric

Details

Report Name

Oral Proteins and Peptides Market

Market size in 2020

US$ 751.8 Million

The revenue forecast in 2027

US$ 1214.6 Million

Growth Rate

CAGR of 6.6% from 2021 to 2027

Market size available for years

2020-2027

Forecast units

Value (USD) & Volume (Units)

Segments covered

Types, End-User / Applications, Companies, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Index

1 Oral Proteins and Peptides Market Overview
1.1 Product Overview and Scope of Oral Proteins and Peptides
1.2 Oral Proteins and Peptides Segment by Type
1.2.1 Global Oral Proteins and Peptides Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Linaclotide
1.2.3 Calcitonin
1.2.4 Insulin
1.2.5 Octreotide
1.3 Oral Proteins and Peptides Segment by Application
1.3.1 Global Oral Proteins and Peptides Sales Comparison by Application: (2021-2027)
1.3.2 Gastric & Digestive Disorders
1.3.3 Bone Diseases
1.3.4 Diabetes
1.3.5 Hormonal Disorders
1.4 Global Oral Proteins and Peptides Market Size Estimates and Forecasts
1.4.1 Global Oral Proteins and Peptides Revenue 2016-2027
1.4.2 Global Oral Proteins and Peptides Sales 2016-2027
1.4.3 Oral Proteins and Peptides Market Size by Region: 2016 Versus 2021 Versus 2027

2 Oral Proteins and Peptides Market Competition by Manufacturers
2.1 Global Oral Proteins and Peptides Sales Market Share by Manufacturers (2016-2021)
2.2 Global Oral Proteins and Peptides Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Oral Proteins and Peptides Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Oral Proteins and Peptides Manufacturing Sites, Area Served, Product Type
2.5 Oral Proteins and Peptides Market Competitive Situation and Trends
2.5.1 Oral Proteins and Peptides Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oral Proteins and Peptides Players Market Share by Revenue
2.5.3 Global Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Oral Proteins and Peptides Retrospective Market Scenario by Region
3.1 Global Oral Proteins and Peptides Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Oral Proteins and Peptides Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Oral Proteins and Peptides Market Facts & Figures by Country
3.3.1 North America Oral Proteins and Peptides Sales by Country
3.3.2 North America Oral Proteins and Peptides Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oral Proteins and Peptides Market Facts & Figures by Country
3.4.1 Europe Oral Proteins and Peptides Sales by Country
3.4.2 Europe Oral Proteins and Peptides Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oral Proteins and Peptides Market Facts & Figures by Region
3.5.1 Asia Pacific Oral Proteins and Peptides Sales by Region
3.5.2 Asia Pacific Oral Proteins and Peptides Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oral Proteins and Peptides Market Facts & Figures by Country
3.6.1 Latin America Oral Proteins and Peptides Sales by Country
3.6.2 Latin America Oral Proteins and Peptides Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oral Proteins and Peptides Market Facts & Figures by Country
3.7.1 Middle East and Africa Oral Proteins and Peptides Sales by Country
3.7.2 Middle East and Africa Oral Proteins and Peptides Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Oral Proteins and Peptides Historic Market Analysis by Type
4.1 Global Oral Proteins and Peptides Sales Market Share by Type (2016-2021)
4.2 Global Oral Proteins and Peptides Revenue Market Share by Type (2016-2021)
4.3 Global Oral Proteins and Peptides Price by Type (2016-2021)

5 Global Oral Proteins and Peptides Historic Market Analysis by Application
5.1 Global Oral Proteins and Peptides Sales Market Share by Application (2016-2021)
5.2 Global Oral Proteins and Peptides Revenue Market Share by Application (2016-2021)
5.3 Global Oral Proteins and Peptides Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Allergan Oral Proteins and Peptides Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
6.2.4 AstraZeneca Oral Proteins and Peptides Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Biocon
6.3.1 Biocon Corporation Information
6.3.2 Biocon Description and Business Overview
6.3.3 Biocon Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Biocon Oral Proteins and Peptides Product Portfolio
6.3.5 Biocon Recent Developments/Updates
6.4 Generex Biotechnology
6.4.1 Generex Biotechnology Corporation Information
6.4.2 Generex Biotechnology Description and Business Overview
6.4.3 Generex Biotechnology Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Generex Biotechnology Oral Proteins and Peptides Product Portfolio
6.4.5 Generex Biotechnology Recent Developments/Updates
6.5 Novo Nordisk
6.5.1 Novo Nordisk Corporation Information
6.5.2 Novo Nordisk Description and Business Overview
6.5.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Novo Nordisk Oral Proteins and Peptides Product Portfolio
6.5.5 Novo Nordisk Recent Developments/Updates
6.6 Synergy Pharmaceuticals
6.6.1 Synergy Pharmaceuticals Corporation Information
6.6.2 Synergy Pharmaceuticals Description and Business Overview
6.6.3 Synergy Pharmaceuticals Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Synergy Pharmaceuticals Oral Proteins and Peptides Product Portfolio
6.6.5 Synergy Pharmaceuticals Recent Developments/Updates
6.7 Tarsa Therapeutics
6.6.1 Tarsa Therapeutics Corporation Information
6.6.2 Tarsa Therapeutics Description and Business Overview
6.6.3 Tarsa Therapeutics Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Tarsa Therapeutics Oral Proteins and Peptides Product Portfolio
6.7.5 Tarsa Therapeutics Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sanofi Oral Proteins and Peptides Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Hoffmann-La Roche
6.9.1 Hoffmann-La Roche Corporation Information
6.9.2 Hoffmann-La Roche Description and Business Overview
6.9.3 Hoffmann-La Roche Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Hoffmann-La Roche Oral Proteins and Peptides Product Portfolio
6.9.5 Hoffmann-La Roche Recent Developments/Updates
6.10 Synthetic Biologics
6.10.1 Synthetic Biologics Corporation Information
6.10.2 Synthetic Biologics Description and Business Overview
6.10.3 Synthetic Biologics Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Synthetic Biologics Oral Proteins and Peptides Product Portfolio
6.10.5 Synthetic Biologics Recent Developments/Updates
6.11 Hovione
6.11.1 Hovione Corporation Information
6.11.2 Hovione Oral Proteins and Peptides Description and Business Overview
6.11.3 Hovione Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Hovione Oral Proteins and Peptides Product Portfolio
6.11.5 Hovione Recent Developments/Updates
6.12 Novartis
6.12.1 Novartis Corporation Information
6.12.2 Novartis Oral Proteins and Peptides Description and Business Overview
6.12.3 Novartis Oral Proteins and Peptides Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Novartis Oral Proteins and Peptides Product Portfolio
6.12.5 Novartis Recent Developments/Updates

7 Oral Proteins and Peptides Manufacturing Cost Analysis
7.1 Oral Proteins and Peptides Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oral Proteins and Peptides
7.4 Oral Proteins and Peptides Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oral Proteins and Peptides Distributors List
8.3 Oral Proteins and Peptides Customers

9 Oral Proteins and Peptides Market Dynamics
9.1 Oral Proteins and Peptides Industry Trends
9.2 Oral Proteins and Peptides Growth Drivers
9.3 Oral Proteins and Peptides Market Challenges
9.4 Oral Proteins and Peptides Market Restraints

10 Global Market Forecast
10.1 Oral Proteins and Peptides Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oral Proteins and Peptides by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Oral Proteins and Peptides by Type (2022-2027)
10.2 Oral Proteins and Peptides Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oral Proteins and Peptides by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Oral Proteins and Peptides by Application (2022-2027)
10.3 Oral Proteins and Peptides Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oral Proteins and Peptides by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Oral Proteins and Peptides by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Oral Proteins and Peptides Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Oral Proteins and Peptides Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Oral Proteins and Peptides Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Oral Proteins and Peptides Covered in This Study
Table 5. Global Oral Proteins and Peptides Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Oral Proteins and Peptides Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Oral Proteins and Peptides Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Oral Proteins and Peptides Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Oral Proteins and Peptides Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Oral Proteins and Peptides Manufacturing Sites and Area Served
Table 11. Manufacturers Oral Proteins and Peptides Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oral Proteins and Peptides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Proteins and Peptides as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Oral Proteins and Peptides Sales by Region (2016-2021) & (K MT)
Table 16. Global Oral Proteins and Peptides Sales Market Share by Region (2016-2021)
Table 17. Global Oral Proteins and Peptides Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Oral Proteins and Peptides Sales by Country (2016-2021) & (K MT)
Table 19. North America Oral Proteins and Peptides Sales Market Share by Country (2016-2021)
Table 20. North America Oral Proteins and Peptides Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Oral Proteins and Peptides Revenue Market Share by Country (2016-2021)
Table 22. Europe Oral Proteins and Peptides Sales by Country (2016-2021) & (K MT)
Table 23. Europe Oral Proteins and Peptides Sales Market Share by Country (2016-2021)
Table 24. Europe Oral Proteins and Peptides Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Oral Proteins and Peptides Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Oral Proteins and Peptides Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Oral Proteins and Peptides Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Oral Proteins and Peptides Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Oral Proteins and Peptides Revenue Market Share by Region (2016-2021)
Table 30. Latin America Oral Proteins and Peptides Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Oral Proteins and Peptides Sales Market Share by Country (2016-2021)
Table 32. Latin America Oral Proteins and Peptides Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Oral Proteins and Peptides Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Oral Proteins and Peptides Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Oral Proteins and Peptides Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Oral Proteins and Peptides Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Country (2016-2021)
Table 38. Global Oral Proteins and Peptides Sales (K MT) by Type (2016-2021)
Table 39. Global Oral Proteins and Peptides Sales Market Share by Type (2016-2021)
Table 40. Global Oral Proteins and Peptides Revenue (Million US$) by Type (2016-2021)
Table 41. Global Oral Proteins and Peptides Revenue Share by Type (2016-2021)
Table 42. Global Oral Proteins and Peptides Price (USD/MT) by Type (2016-2021)
Table 43. Global Oral Proteins and Peptides Sales (K MT) by Application (2016-2021)
Table 44. Global Oral Proteins and Peptides Sales Market Share by Application (2016-2021)
Table 45. Global Oral Proteins and Peptides Revenue (Million US$) by Application (2016-2021)
Table 46. Global Oral Proteins and Peptides Revenue Share by Application (2016-2021)
Table 47. Global Oral Proteins and Peptides Price (USD/MT) by Application (2016-2021)
Table 48. Allergan Corporation Information
Table 49. Allergan Description and Business Overview
Table 50. Allergan Oral Proteins and Peptides Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Allergan Oral Proteins and Peptides Product
Table 52. Allergan Recent Developments/Updates
Table 53. AstraZeneca Corporation Information
Table 54. AstraZeneca Description and Business Overview
Table 55. AstraZeneca Oral Proteins and Peptides Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. AstraZeneca Oral Proteins and Peptides Product
Table 57. AstraZeneca Recent Developments/Updates
Table 58. Biocon Corporation Information
Table 59. Biocon Description and Business Overview
Table 60. Biocon Oral Proteins and Peptides Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Biocon Oral Proteins and Peptides Product
Table 62. Biocon Recent Developments/Updates
Table 63. Generex Biotechnology Corporation Information
Table 64. Generex Biotechnology Description and Business Overview
Table 65. Generex Biotechnology Oral Proteins and Peptides Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Generex Biotechnology Oral Proteins and Peptides Product
Table 67. Generex Biotechnology Recent Developments/Updates
Table 68. Novo Nordisk Corporation Information
Table 69. Novo Nordisk Description and Business Overview
Table 70. Novo Nordisk Oral Proteins and Peptides Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Novo Nordisk Oral Proteins and Peptides Product
Table 72. Novo Nordisk Recent Developments/Updates
Table 73. Synergy Pharmaceuticals Corporation Information
Table 74. Synergy Pharmaceuticals Description and Business Overview
Table 75. Synergy Pharmaceuticals Oral Proteins and Peptides Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Synergy Pharmaceuticals Oral Proteins and Peptides Product
Table 77. Synergy Pharmaceuticals Recent Developments/Updates
Table 78. Tarsa Therapeutics Corporation Information
Table 79. Tarsa Therapeutics Description and Business Overview
Table 80. Tarsa Therapeutics Oral Proteins and Peptides Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Tarsa Therapeutics Oral Proteins and Peptides Product
Table 82. Tarsa Therapeutics Recent Developments/Updates
Table 83. Sanofi Corporation Information
Table 84. Sanofi Description and Business Overview
Table 85. Sanofi Oral Proteins and Peptides Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Sanofi Oral Proteins and Peptides Product
Table 87. Sanofi Recent Developments/Updates
Table 88. Hoffmann-La Roche Corporation Information
Table 89. Hoffmann-La Roche Description and Business Overview
Table 90. Hoffmann-La Roche Oral Proteins and Peptides Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Hoffmann-La Roche Oral Proteins and Peptides Product
Table 92. Hoffmann-La Roche Recent Developments/Updates
Table 93. Synthetic Biologics Corporation Information
Table 94. Synthetic Biologics Description and Business Overview
Table 95. Synthetic Biologics Oral Proteins and Peptides Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Synthetic Biologics Oral Proteins and Peptides Product
Table 97. Synthetic Biologics Recent Developments/Updates
Table 98. Hovione Corporation Information
Table 99. Hovione Description and Business Overview
Table 100. Hovione Oral Proteins and Peptides Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Hovione Oral Proteins and Peptides Product
Table 102. Hovione Recent Developments/Updates
Table 103. Novartis Corporation Information
Table 104. Novartis Description and Business Overview
Table 105. Novartis Oral Proteins and Peptides Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Novartis Oral Proteins and Peptides Product
Table 107. Novartis Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Oral Proteins and Peptides Distributors List
Table 111. Oral Proteins and Peptides Customers List
Table 112. Oral Proteins and Peptides Market Trends
Table 113. Oral Proteins and Peptides Growth Drivers
Table 114. Oral Proteins and Peptides Market Challenges
Table 115. Oral Proteins and Peptides Market Restraints
Table 116. Global Oral Proteins and Peptides Sales Forecast by Type (2022-2027) & (K MT)
Table 117. Global Oral Proteins and Peptides Sales Market Share Forecast by Type (2022-2027)
Table 118. Global Oral Proteins and Peptides Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 119. Global Oral Proteins and Peptides Revenue Market Share Forecast by Type (2022-2027)
Table 120. Global Oral Proteins and Peptides Sales Forecast by Application (2022-2027) & (K MT)
Table 121. Global Oral Proteins and Peptides Sales Market Share Forecast by Application (2022-2027)
Table 122. Global Oral Proteins and Peptides Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 123. Global Oral Proteins and Peptides Revenue Market Share Forecast by Application (2022-2027)
Table 124. Global Oral Proteins and Peptides Sales Forecast by Region (2022-2027) & (K MT)
Table 125. Global Oral Proteins and Peptides Sales Market Share Forecast by Region (2022-2027)
Table 126. Global Oral Proteins and Peptides Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 127. Global Oral Proteins and Peptides Revenue Market Share Forecast by Region (2022-2027)
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Proteins and Peptides
Figure 2. Global Oral Proteins and Peptides Market Share by Type in 2020 & 2027
Figure 3. Linaclotide Product Picture
Figure 4. Calcitonin Product Picture
Figure 5. Insulin Product Picture
Figure 6. Octreotide Product Picture
Figure 7. Global Oral Proteins and Peptides Market Share by Application in 2020 & 2027
Figure 8. Gastric & Digestive Disorders
Figure 9. Bone Diseases
Figure 10. Diabetes
Figure 11. Hormonal Disorders
Figure 12. Global Oral Proteins and Peptides Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Oral Proteins and Peptides Market Size 2016-2027 (US$ Million)
Figure 14. Global Oral Proteins and Peptides Sales 2016-2027 (K MT)
Figure 15. Global Oral Proteins and Peptides Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Oral Proteins and Peptides Sales Share by Manufacturers in 2020
Figure 17. Global Oral Proteins and Peptides Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Oral Proteins and Peptides Players: Market Share by Revenue in 2020
Figure 19. Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Oral Proteins and Peptides Sales Market Share by Region (2016-2021)
Figure 21. Global Oral Proteins and Peptides Sales Market Share by Region in 2020
Figure 22. Global Oral Proteins and Peptides Revenue Market Share by Region (2016-2021)
Figure 23. Global Oral Proteins and Peptides Revenue Market Share by Region in 2020
Figure 24. U.S. Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Oral Proteins and Peptides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Oral Proteins and Peptides by Type (2016-2021)
Figure 49. Sales Market Share of Oral Proteins and Peptides by Application (2016-2021)
Figure 50. Sales Market Share of Oral Proteins and Peptides by Application in 2020
Figure 51. Revenue Share of Oral Proteins and Peptides by Application (2016-2021)
Figure 52. Revenue Share of Oral Proteins and Peptides by Application in 2020
Figure 53. Manufacturing Cost Structure of Oral Proteins and Peptides
Figure 54. Manufacturing Process Analysis of Oral Proteins and Peptides
Figure 55. Oral Proteins and Peptides Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’